Estar Technologies

Estar Technologies is a leading medical device and biotechnology company specializing in the field of regenerative medicine and autologous cell therapies. The company is globally recognized for its proprietary Platelet-Rich Plasma (PRP) separation systems, marketed under the flagship brands Tropocells and Cellenis. Their technology utilizes a unique thixotropic gel to efficiently isolate and concentrate platelets and essential growth factors from a patient's own blood at the point of care. These products are extensively used in clinical applications ranging from medical aesthetics and dermatology to orthopedics and chronic wound management. Headquartered in Israel, Estar Technologies maintains a strong international presence through strategic distribution partnerships and a commitment to evidence-based clinical outcomes.